This NAPWHA breakfast discussion at the 2019 Australasian HIV&AIDS Conference in Perth provides an opportunity for multi-disciplinary delegates to hear and gain insight and current information from leaders in the field working in the field of HIV criminalisation in Australia and the region.
This NAPWHA evening at the 2019 Australasian HIV&AIDS Conference in Perth discussion will bring together experts including community representatives, clinicians and researchers who are involved in the HIV response in these Papua New Guinea (PNG) and Timor Leste to identify current problems and issues and to investigate solutions.
NAPWHA wish to update our HIV community/ies and organisational members that from 1 March 2020 the Single Tablet Regimen (STR) HIV treatments Eviplera ® (tenofovir disoproxil fumarate, emtricitabine and rilpivirine) and Stribild ® (cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate) will no longer be available via the Australian Pharmaceutical Benefits Scheme (PBS).
Nominations for the NAPWHA Board of Directors is now open until Monday 23 September 2019. This is a fantastic opportunity for inspirational leaders who have a genuine passion for advancing the rights of people living with HIV.
NAPWHA pays our respects to Noel Offer who sadly passed away recently, and her loved ones are in our thoughts at this time. PrEP & HIV advocate Steve Spencer delivered this tribute to her lasting legacy in HIV Prevention: "Noel Offer’s impact on the world’s...
Celebrating the lives, bravery and advocacy of those who paved the way on HIV Long Term Survivors Day
June 5th is HIV Long Term Survivors Day and NAPWHA commemorate and celebrate the lives, bravery and advocacy of those who paved the way for every facet of the HIV response — with a message from our special representative, David Menadue.